Literature DB >> 1150227

Excretion of urinary testosterone in Klinefelter's syndrome.

H Niermann, H Lenau, G Ayi-Bonte, H Schulz.   

Abstract

The urinary testosterone excretion in 55 patients with Klinefelter's syndrome was determined by gas-chromatographic methods. The mean testosterone level in the group of Klinefelter patients was significantly decreased (15.7 mug/24 hrs) compared with the excretion by 30 normal men (44.1 mug/24 hrs). An age dependency of excretion levles was not obvious in chromatin-positive men when compared to healthy subjects. A correlation between testosterone excretion and configuration types seemed to be probable by reason of observations and statistical values. Average testosterone excretion increased with increasing normalization of body proportions. Gynecomastia was noticed in 56% of those examined. With increasing severity of gynecomastia the mean testosterone levels decreased. A correlation between beard and body hair, which was decreased in almost all subjects, and testosterone excreiton was not visible. With diminishing mean testosterone excretion an increase of osteoporosis seemed to be probable. A statistically significant difference was found when comparing patients who never had ejaculations with those who had regular libido and ejaculations. Klinefelter patients who had not succeeded in completing school or an occupational education showed a significantly decreased testosterone level as compared with others who had a profession.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1150227     DOI: 10.1007/bf00280285

Source DB:  PubMed          Journal:  Humangenetik        ISSN: 0018-7348


  12 in total

1.  A CLINICAL STUDY OF 100 CHROMATIN-POSITIVE MEN.

Authors:  J RABOCH
Journal:  Fertil Steril       Date:  1964 May-Jun       Impact factor: 7.329

2.  TESTOSTERONE PRODUCTION IN CHROMATIN-POSITIVE KLINEFELTER'S SYNDROME.

Authors:  M B LIPSETT; T E DAVIS; H WILSON; C J CANFIELD
Journal:  J Clin Endocrinol Metab       Date:  1965-08       Impact factor: 5.958

3.  MEASUREMENT OF TESTOSTERONE EXCRETION AND PRODUCTION RATE BY GLASS PAPER CHROMATOGRAPHY.

Authors:  N Y LIM; J F DINGMAN
Journal:  J Clin Endocrinol Metab       Date:  1965-05       Impact factor: 5.958

4.  Synthesis of testosterone by subjects with gonadal dysgenesis and XXY chromosome constitution.

Authors:  W R SLAUNWHITE; A A SANDBERG; W J STAUBITZ; J E JACKSON; G F KOEPF
Journal:  J Clin Endocrinol Metab       Date:  1962-10       Impact factor: 5.958

5.  Klinefelter's syndrome: clinical and hormonal aspects.

Authors:  J S STEWART; W S MACK; A D GOVAN; M A FERGUSON-SMITH; B LENNOX
Journal:  Q J Med       Date:  1959-10

6.  [Discrepancy between findings on chromatin & genetic sex in the Klinefelter syndrome].

Authors:  H NOWAKOWSKI; W LENZ; J PARADA
Journal:  Acta Endocrinol (Copenh)       Date:  1959-02

7.  Psychopathology of Klinefelter's syndrome; review of thirty-one cases.

Authors:  R Q PASQUALINI; G VIDAL; G E BUR
Journal:  Lancet       Date:  1957-07-27       Impact factor: 79.321

8.  [Testosterone secretion in male persons under normal and pathological conditions].

Authors:  H Schmidt
Journal:  Acta Endocrinol (Copenh)       Date:  1968

9.  Androgen production in hypogonadal men.

Authors:  S L Jeffcoate; R V Brooks; N Y Lim; D R London; F T Prunty; G S Spathis
Journal:  J Endocrinol       Date:  1967-04       Impact factor: 4.286

10.  Clinical and therapeutic experiences with Klinefelter's syndrome.

Authors:  K L Becker
Journal:  Fertil Steril       Date:  1972-08       Impact factor: 7.329

View more
  2 in total

1.  [A case of testicular feminization with the karyotype 47, XXY (author's transl)].

Authors:  M Bartsch-Sandhoff; L Stephan; G Röhrborn; I H Pawlowitzki; W Scholz
Journal:  Hum Genet       Date:  1976-01-28       Impact factor: 4.132

2.  Testosterone levels and gonadotrophins in Klinefelter's patients treated with injections of mesterolone cipionate.

Authors:  P M Kövary; H Lenau; H Niermann; E Zierden; H Wagner
Journal:  Arch Dermatol Res       Date:  1977-05-27       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.